Aurobindo Pharma soars on reporting 79% rise in Q4 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Aurobindo Pharma is currently trading at Rs. 1214.65, up by 19.00 points or 1.59% from its previous closing of Rs. 1195.65 on the BSE.
The scrip opened at Rs. 1217.85 and has touched a high and low of Rs. 1225.00 and Rs. 1208.40 respectively. So far 12735 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1245.60 on 24-May-2024 and a 52 week low of Rs. 584.55 on 29-May-2023.
Last one week high and low of the scrip stood at Rs. 1245.60 and Rs. 1191.25 respectively. The current market cap of the company is Rs. 71124.16 crore.
The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 41.30% and 6.87% respectively.
Aurobindo Pharma has reported 10.28% fall in its net profit at Rs 578.67 crore for fourth quarter ended March 31, 2024 as compared to Rs 644.97 crore for the same quarter in the previous year. However, total income of the company increased by 12.31% at Rs 3,017.00 crore for Q4FY24 as compared Rs 2,686.42 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 79.35% rise in its net profit at Rs 907.35 crore for fourth quarter ended March 31, 2024 as compared to Rs 505.91 crore for the same quarter in the previous year. Total income of the company increased by 16.77% at Rs 7,715.77 crore for Q4FY24 as compared Rs 6,607.87 crore for the corresponding quarter previous year.
For the year ended March 31, 2024, the company has reported 59.25% rise in its net profit at Rs 1,954.14 crore as compared to Rs 1,227.11 crore for the previous year. Total income of the company increased by 26.52% at Rs 11,261.70 crore for year under review as compared to Rs 8,900.92 crore for year ended March 31, 2023.
For the year ended March 31, 2024, on the consolidated basis, the company has reported 64.40% rise in its net profit at Rs 3,168.97 crore as compared to Rs 1,927.65 crore for the previous year. Total income of the company increased by 17.55% at Rs 29,559.25 crore for year under review as compared to Rs 25,145.97 crore for year ended March 31, 2023.
